Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system

Voprosy Onkologii

Volumn 50, Issue 2, 2004, Pages 169-173

  Berstein, L M ^a   Zimarina, T S ^a   Tsyrlina, Ye V ^a   Kovalevsky, A Yu ^a   Imyanitov, Ye N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; CYTOCHROME P450 17; CYTOCHROME P450 19; CYTOCHROME P450 1B1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; STEROID RECEPTOR; UNCLASSIFIED DRUG; AROMATASE; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; PROGESTERONE RECEPTOR; STEROID 17ALPHA MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE;

ALLELE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESTROGEN SYNTHESIS; FEMALE; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; ADULT; AGED; BREAST TUMOR; CHEMISTRY; ENDOMETRIUM TUMOR; ENZYMOLOGY; GENETICS; MIDDLE AGED;

ADULT; AGED; AROMATASE; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 3042536361     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bailey L.R., Roodi N., Dupont W.D., Parl F.F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer // Cancer Res. - 1998. - Vol. - 58. - P. 5038-5041.
2. Bardou V.J., Arpino G., Elledge R.M. et al. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases // J. Clin. Oncol. - 2003. - Vol. - 21. - P. 1973-1979.
3. Barnes D.M., Harris W.H., Smith P. et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients // Brit. J. Cancer. - 1996. - Vol. - 74. - P. 1445-1451.
4. Berstein L.M., Imyanitov E.N., Suspitsin E.N et al. CYP19 gene polymorphism in endometrial cancer patients // J. Cancer Res. Clin. Oncol. - 2001. - Vol. 127. - P. 135-138.
5. Cavalieri E., Frenkel K., Liehr J.G. et al. Estrogens as endogenous genotoxic agents - DNA adducts and mutations // J. Natl. Cancer Inst. Monograph. - 2000. - Vol. 27. - P. 75-94.
6. De Vivo I., Hankinson S.E., Li L. et al. Association of CYP1B1 polymorphisms and breast cancer risk // Cancer Epidemiol. Biomarkers Prev. - 2002. - Vol. 11. - P. 489-492.
7. Khan S.A., Rogers M.A.M., Khurana K.K. et al. Estrogen receptor expression in benign breast epithelium and breast cancer risk // J. Nat. Cancer Inst. - 1998. - Vol. 90. - P. 37-42.
8. Kuligina E.S., Togo A.V., Suspitsin E.N. et al. CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women // Cancer Lett. - 2000. - Vol. 156. - P. 5-50.
9. Manjer J., Malina J., Berglund G., Bondeson I., Garńe J.P., Janzon L. Smoking associated with hormone receptor negative breast cancer // Int. J. Cancer. - 2001. - Vol. 91. - P. 580-584.
10. Miyoshi Y., Ando A., Hasegawa S. et al. Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk // Europ. J. Cancer. - 2003. - Vol. 39. - P. 2531-2537.
11. Mullenbach R., Lagoda P.J., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues // Trends Genet. - 1989. - Vol. 5. - P. 391.
12. Saez S., Martin P.M., Chouvet C.D. Oestradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels // Cancer Res. - 1978. - Vol. 38. - P. 3468-3473.
13. Sasaki M., Tanaka Y., Kaneuchi M. et al. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions // Cancer Res. - 2003. - Vol. 63. - P. 3913-3918.
14. Shimada T., Watanabe J., Inoue K. et al. Specificity of 17 beta - estradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119 and 432 // Xenobiotica. - 2001. - Vol. 31. - P. 163-176.
15. Sorlie T., Perou C., Tibshirani R. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications // Proc. Natl. Acad. Sci. (USA). - 2001. - Vol. 98. - P. 10869-10874.
16. Tarone R.E., Chu K.C. The greater impact of menopause on ER- than ER+ cancer incidence: a possible explanation (United States) // Cancer Causes and Control. - 2002. - Vol. 13. - P. 7-14.
17. Yasui Y., Potter J. The shape of age-incidence curves of female breast cancer by hormone-receptor status // Cancer Causes Control. - 1999. - Vol. 10. - P. 431-437.